The Cannabist Company Expands New Jersey Footprint with Opening of Cannabist Mays Landing

The Cannabist Company (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) ("The Cannabist Company” or the "Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the U.S., announced today the opening of its third dispensary in Mays Landing, New Jersey. The location, at 4476 Black Horse Pike, marks the company’s third dispensary in the Garden State, expanding access to medical cannabis patients. Adult-use sales will commence in early 2025, subject to regulatory approval.

"We’re proud to open our third Cannabist location in Mays Landing to help meet the growing needs of New Jersey’s medical cannabis community. We’ve had tremendous success expanding the offerings for our patients and are excited to keep the momentum going in one of our top markets,” said Jesse Channon, President, The Cannabist Company. "This location reflects our dedication to providing patients with high-quality products, personalized services and access to experienced retail associates. We are honored to be supporting our medical patients now and, in the future, bringing our trusted brands and exceptional retail experience to adult-use customers in the region later this winter.”

The Cannabist Company has established itself as a leading operator in the New Jersey market with a total cultivation and production capacity of 320,000 square feet, including a recently upgraded commercial kitchen and manufacturing space, which positions the company to meet growing product demands while supporting both medical and adult-use cannabis sales. The Mays Landing dispensary joins the Company’s existing retail locations in Deptford and Vineland, as well as a growing wholesale program.

For more information on Cannabist locations, hours and menu availability in New Jersey, visit gocannabist.com/newjersey. For more information on The Cannabist Company visit https://cannabistcompany.com/.

About The Cannabist Company (f/k/a Columbia Care)

The Cannabist Company, formerly known as Columbia Care, is one of the most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 14 U.S. jurisdictions. The Company operates 89 facilities including 70 dispensaries and 19 cultivation and manufacturing facilities, including those under development. Columbia Care, now The Cannabist Company, is one of the original multi-state providers of cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the Company launched Cannabist, its retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit www.cannabistcompany.com.

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute "forward-looking information” or "forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives in New Jersey. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. In addition, security holders should review the risk factors discussed under "Risk Factors” in Columbia Care’s Form 10-K for the year ended December 31, 2023, as filed with Canadian and U.S. securities regulatory authorities and described from time to time in subsequent documents filed with applicable securities regulatory authorities.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250106678223/en/